Core Points - Zion Home Remodeling has been recognized as a "2025 Nextdoor Neighborhood Fave," highlighting its exceptional service and strong community trust in Maryland [1][4] - The award enhances the visibility of Zion Home Remodeling on the Nextdoor platform, providing a badge and a window sticker to signify its status as a top local business [3] Company Overview - Zion Home Remodeling specializes in kitchen remodeling, bathroom renovation, and basement finishing services across Maryland, focusing on quality craftsmanship and client-first commitment [9][10] - The company has established a reputation for delivering modern upgrades and transformations in various areas, including Clinton, Bowie, College Park, and Cheverly [9][10] Leadership and Community Impact - Antulio Lopez, the Founder and CEO, expressed gratitude for the recognition, emphasizing the importance of trust from the community [5][6] - The company is motivated by the positive feedback from clients, which drives them to maintain high standards in their work [7]

Core Insights - Benz Mining Corp has confirmed significant high-grade gold extensions at Zone 126 and the discovery of a new Lens 5 at the Glenburgh Gold Project in Western Australia, with the deepest intercept recorded at over 150 grams per meter [1][3][10]. Group 1: Zone 126 Developments - Ongoing drilling at Zone 126 has revealed a major down-dip extension, with hole 25GLR117 returning 15 meters at 12.7 grams per ton (g/t) gold from 850 meters, marking a 200-meter step-out from previous drilling [5][10]. - Lens 4 has shown significant growth, with a new intercept of 20 meters at 5 g/t gold from 676 meters, extending the lens further to the west [5][11]. - All lenses from 1 to 5 remain open at depth, indicating substantial potential for further high-grade gold additions [7][14]. Group 2: New Discoveries and Future Targets - The new Lens 5 discovery has been confirmed with an intercept of 2 meters at 16.8 g/t gold from 528 meters, suggesting thicker and higher-grade mineralization may be found down-dip [5][13]. - The NE3 and Hurricane targets have been identified as the next high-grade discovery corridors, with NE3 interpreted as an opposing fold limb to Zone 126 and Hurricane presenting a 1 km long gold-in-soil anomaly [8][16]. - Both targets have shown potential for discoveries comparable in size and scale to the Zone 126 trend, with historical drilling intersecting high-grade mineralization near the surface [9][17]. Group 3: Geological Insights and Project Potential - The Glenburgh Gold Project is emerging as a new frontier gold district with multi-million-ounce potential, featuring a mineralized corridor of 18-20 kilometers [36][37]. - The combination of thick, bulk-style gold mineralization and multiple high-grade underground lenses positions Glenburgh as a unique opportunity in the Australian gold sector [37][41]. - The project is supported by advanced geological techniques and a deep understanding of the geological framework, which is expected to enhance exploration success [42][34].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Synopsys, Inc. securities between December 4, 2024, and September 9, 2025, of the December 30, 2025, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Synopsys securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3][6]. - The deadline to move the Court to serve as lead plaintiff is December 30, 2025, and a lead plaintiff represents other class members in directing the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Synopsys' management made materially false and misleading statements and failed to disclose adverse facts about the company's business and prospects [5]. - Specific claims include the negative impact of Synopsys' focus on artificial intelligence customers on its Design IP business and the misleading nature of positive statements made by the defendants [5].

New York, New York--(Newsfile Corp. - December 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of investors in cryptocurrency issued by Balancer (ticker: BAL), resulting from allegations that Balancer may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Balancer cryptocurrency you may be entitled to compensation without payment of any out of pocket fees or costs thr ...

Core Viewpoint - A class action lawsuit has been filed against DeFi Technologies, Inc. for misleading statements made during the Class Period from May 12, 2025, to November 14, 2025, potentially impacting investors' financial outcomes [1][5]. Group 1: Lawsuit Details - The lawsuit claims that DeFi Technologies made false and misleading statements regarding delays in executing its DeFi arbitrage strategy, which is a key revenue driver [5]. - It is alleged that the company understated the competition it faced from other digital asset treasury companies, affecting its ability to execute its strategy [5]. - The lawsuit asserts that DeFi Technologies was unlikely to meet its previously issued revenue guidance for the fiscal year 2025 due to these issues [5]. Group 2: Investor Actions - Investors who purchased DeFi Technologies securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who bought or sold Cepton, Inc. (NASDAQ: CPTN) common stock between July 29, 2024, and January 6, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased or sold Cepton common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must file a motion with the Court by December 8, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations during the Class Period [5]. - Specific allegations include the failure to disclose a credible third-party bid valuing Cepton at more than double the Koito Acquisition, and the Board's lack of meaningful exploration of this offer [5]. - As a result, shareholders were deprived of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Viewpoint - A class action lawsuit has been initiated against Blue Owl Capital Inc. for alleged misleading statements and undisclosed liquidity issues affecting its business operations during the specified period [2][6]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between February 6, 2025, and November 16, 2025 [2]. - Allegations include that Blue Owl faced significant pressure on its asset base due to business development companies (BDC) redemptions, leading to undisclosed liquidity issues [6]. - The lawsuit claims that the defendants downplayed the severity of these issues, resulting in materially misleading statements about Blue Owl's business prospects [6]. Group 2: Investor Actions - Investors who purchased or sold Blue Owl securities during the class period may be entitled to compensation without upfront costs through a contingency fee arrangement [3]. - Interested investors can join the class action by submitting a form or contacting the law firm directly [4][7]. - A lead plaintiff must be appointed by February 2, 2026, to represent the class in the litigation [2][4]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [5]. - The firm emphasizes the importance of selecting qualified legal counsel with proven success in similar cases [5].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for allegedly providing misleading information regarding its financial performance and property value during the specified Class Period from January 27, 2025, to October 27, 2025 [2][6][7] Group 1: Lawsuit Details - The lawsuit claims that the defendants provided investors with overly positive statements about Alexandria Real Estate's expected revenue and funds from operations (FFO) growth for the 2025 fiscal year, particularly regarding its real estate operations [6] - It is alleged that while making these positive statements, the defendants concealed material adverse facts about the true state of its Long Island City (LIC) property, particularly its leasing value as a life-science destination [7] Group 2: Investor Actions - Investors who purchased Alexandria Real Estate Equities securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] - To participate in the class action, investors must move the Court to serve as lead plaintiff by January 26, 2026 [4][9] Group 3: Legal Representation - The Rosen Law Firm encourages investors to select qualified counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [5] - The firm has been recognized for its leadership in securities class action settlements, including a notable settlement against a Chinese company [5]

Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the lawsuit is from August 6, 2024, to August 4, 2025, during which investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A class action lawsuit has already been filed, and investors wishing to serve as lead plaintiffs must act by January 5, 2026 [4][6]. Group 2: Allegations Against Inspire Medical - The lawsuit alleges that Inspire Medical misrepresented and failed to disclose critical information regarding the Inspire V sleep apnea device, including its actual market demand and the necessary steps for its launch [6]. - Defendants are accused of issuing materially false and misleading statements that led investors to believe in strong demand for the Inspire V device, resulting in investor damages when the true situation was revealed [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions of dollars for investors [5]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company at that time and ranking highly in the number of settlements since 2013 [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 15, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - Investors who purchased MoonLake common stock between March 10, 2024, and September 29, 2025, may be eligible for compensation without any upfront costs through a contingency fee arrangement [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. Group 2: Case Allegations - The complaint alleges that during the class period, the defendants made false or misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, specifically concerning its molecular targets and clinical benefits [5]. - The lawsuit claims that when the true information was revealed, investors suffered damages due to the misleading nature of the defendants' statements [5].